Coronary artery disease
Conditions
Interventions
Sequential group:Sequential grafting of in situ skeletonized left internal mammary artery to the diagonal artery and then to the LAD
Control group:Separate grafting of in situ skeletonized left internal mammary artery to the LAD
Sponsors
Department of Cardiac surgery, Zhongshan Hospital Fudan University
Eligibility
Sex/Gender
All
Age
No minimum to 70 Years
Inclusion criteria
Inclusion criteria: Patients with coronary artery disease who suffered from triple-vessel disease receiving first, scheduled, isolated CABG procedure with bilateal or single in situ skeletonized internal mammary artery grafting; patients with life expectancy over 10 years; all participants or guardians gave written informed consent.
Exclusion criteria
Exclusion criteria: Patients were excluded from this study on the basis of the following criteria: any concomitant diseases including renal insufficiency, malignant tumor, and chronic obstructive pulmonary disease; and a history of chest radiotherapy. Patients who failed to receive dual antiplatelet therapy were also excluded from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Surgical mortality;Major postoperative morbidity;Follow-up survival;Repeat revascularization;LIMA graft patency; | — |
Countries
China
Contacts
Public ContactJi Qiang
Department of Cardiac surgery, Zhongshan Hospital Fudan University
Outcome results
None listed